Table 1.
Baseline Demographics and Subject Characteristics
| Parameter | Atorvastatin (n = 24) | Digoxin (n = 24) | Metformin (n = 24) | Methotrexate (n = 24) |
|---|---|---|---|---|
| Sex, n (%) | ||||
| Male | 13 (54.2) | 18 (75.0) | 18 (75.0) | 24 (100) |
| Female | 11 (45.8) | 6 (25.0) | 6 (25.0) | 0 |
| Race, n (%) | ||||
| White | 18 (75.0) | 7 (29.2) | 14 (58.3) | 14 (58.3) |
| Black or African | 6 (25.0) | 16 (66.7) | 7 (29.2) | 7 (29.2) |
| American | ||||
| Asian | 0 | 1 (4.2) | 3 (12.5) | 2 (8.3) |
| Middle Eastern | 0 | 0 | 0 | 1 (4.2) |
| Ethnicity, n (%) | ||||
| Not Hispanic or Latino | 15 (62.5) | 21 (87.5) | 17 (70.8) | 18 (75.0) |
| Age, years, mean (SD) | 43.1 (9.0) | 37.1 (11.2) | 31.8 (9.6) | 33.5 (10.2) |
| Weight, kg, mean (SD) | 82.2 (13.4) | 82.1 (14.1) | 75.2 (12.2) | 80.1 (12.1) |
| BMI, kg/m2, mean (SD) | 27.8 (3.1) | 26.8 (3.1) | 25.1 (3.2) | 25.9 (3.6) |
BMI, body mass index; SD, standard deviation.